When should RhD-negative recipients be spared the transfusion of DEL red cells to avoid anti-D alloimmunization?
作者信息
Ohto Hitoshi, Flegel Willy Albert, Safic Stanic Hana
机构信息
Departments of Mesenchymal Stem Cell Research, Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
Transfusion. 2022 Nov;62(11):2405-2408. doi: 10.1111/trf.17122. Epub 2022 Sep 26.
Abstract
摘要
相似文献
1
When should RhD-negative recipients be spared the transfusion of DEL red cells to avoid anti-D alloimmunization?
Transfusion. 2022 Nov;62(11):2405-2408. doi: 10.1111/trf.17122. Epub 2022 Sep 26.
2
Alloimmunization of patients by blood units harboring distinct DEL variants.
Immunohematology. 2013;29(4):136-40.
3
Use of an anti-D-alloimmunization kinetics model to correct the interval censored D-alloimmunization rate following red blood cell transfusions.
Transfusion. 2025 May;65 Suppl 1(Suppl 1):S304-S312. doi: 10.1111/trf.18138. Epub 2025 Feb 5.
4
Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative study.
Transfusion. 2025 May;65(5):957-967. doi: 10.1111/trf.18202. Epub 2025 Mar 10.
5
RhD-Alloimmunization in Adult and Pediatric Trauma Patients.
Transfus Med Rev. 2024 Oct;38(4):150842. doi: 10.1016/j.tmrv.2024.150842. Epub 2024 Jul 10.
6
An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.
Blood Transfus. 2014 Apr;12(2):238-43. doi: 10.2450/2013.0184-12. Epub 2013 Feb 6.
7
Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Transfusion. 2024 May;64 Suppl 2:S100-S110. doi: 10.1111/trf.17807. Epub 2024 Apr 2.
8
Rh Immune Globulin After the Transfusion of RhD-Positive Blood in a Patient with a Partial D Antigen.
Obstet Gynecol. 2022 Dec 1;140(6):1052-1055. doi: 10.1097/AOG.0000000000004981. Epub 2022 Nov 2.
9
Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists.
Arch Pathol Lab Med. 2014 May;138(5):620-5. doi: 10.5858/arpa.2013-0141-CP.
10
A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
Transfusion. 2005 Oct;45(10):1561-7. doi: 10.1111/j.1537-2995.2005.00584.x.
引用本文的文献
1
Two Cases of Anti-D Alloimmunization in D-Negative Thai Patients as a Result of the Asian-Type DEL on Transfused Red Cells.
Transfus Med Hemother. 2023 Sep 14;51(2):122-125. doi: 10.1159/000533625. eCollection 2024 Apr.
本文引用的文献
1
A practical and effective strategy in East Asia to prevent anti-D alloimmunization in patients by C/c phenotyping of serologic RhD-negative blood donors.
EJHaem. 2021 Nov;2(4):750-756. doi: 10.1002/jha2.292. Epub 2021 Sep 16.
2
Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
Transfusion. 2022 Aug;62 Suppl 1:S185-S192. doi: 10.1111/trf.16952. Epub 2022 Jun 24.
3
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach.
Transfus Med. 2022 Oct;32(5):366-374. doi: 10.1111/tme.12887. Epub 2022 Jun 6.
4
RhD alloimmunization by DEL variant missed in donor testing.
Transfusion. 2022 May;62(5):1084-1088. doi: 10.1111/trf.16862. Epub 2022 Mar 23.
5
DEL in China: the D antigen among serologic RhD-negative individuals.
J Transl Med. 2021 Oct 20;19(1):439. doi: 10.1186/s12967-021-03116-6.
6
Modern Rhesus (Rh) typing in transfusion and pregnancy.
CMAJ. 2021 Jan 25;193(4):E124. doi: 10.1503/cmaj.201212.
7
Nation-wide investigation of RHD variants in Thai blood donors: Impact for molecular diagnostics.
Transfusion. 2021 Mar;61(3):931-938. doi: 10.1111/trf.16242. Epub 2020 Dec 29.
8
Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts.
Transfusion. 2020 May;60(5):1109-1110. doi: 10.1111/trf.15788.
9
It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies.
Transfusion. 2019 Dec;59(12):3794-3799. doi: 10.1111/trf.15569. Epub 2019 Oct 18.
10
Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).
Transfusion. 2018 Oct;58(10):2260-2264. doi: 10.1111/trf.14944. Epub 2018 Sep 17.
Zotero 插件